"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (TORE-EM-ih-feen) |
| Fareston |
| Oral tablets |
| 60 mg |
| Class: Antiestrogen hormone |
Actions A nonsteroidal antiestrogen that blocks the growth-stimulating effects of estrogen in the tumor. Absorption is not influenced by food. It binds extensively (> 99.5%) to serum proteins. It is extensively metabolized, principally by CYP3A4. Elimination half-life is » 5 days.
Indications Metastatic breast cancer in postmenopausal women.
Contraindications Standard considerations.
Breast Cancer
ADULTS: PO 60 mg once daily with or without food.
Anticonvulsants
May increase toremifene clearance by 2-fold.
CYP3A4
Toremifene may be altered by drugs that inhibit (eg, ketoconazole, itraconazole, macrolides) or induce (eg, phenobarbital, phenytoin, carbamazepine) this enzyme.
Thiazide diuretics
May cause hypercalcemia with agents that reduce renal excretion of calcium.
Warfarin
May increase the hypoprothrombinemic effect of warfarin.
Lab Test Interferences None well documented.
CARDIOVASCULAR: Edema; pulmonary embolism; thrombophlebitis; thrombosis; cerebrovascular accident; transient ischemic attack; cardiac failure; MI. CNS: Dizziness. ENDOCRINE: Hot flashes; sweating. GI: Nausea and vomiting; elevated LFTs. GU: Vaginal discharge; vaginal bleeding; endometrial thickening. METABOLIC: Hypercalcemia. MUSCULOSKELETAL: Bone and tumor pain at initiation of therapy; soft tissue lesions can temporarily increase in size. SPECIALSENSES: Cataracts; dry eyes; abnormal visual fields; corneal keratopathy; glaucoma; abnormal vision; diplopia.
Pregnancy: Category D. Lactation: Undetermined. Children: Safety and efficacy not established. Hypercalcemia and tumor flare: Drugs that decrease renal calcium excretion (eg, thiazide diuretics) may increase the risk of hypercalcemia in patients receiving toremifene. Hepatic dysfunction: Metabolized in the liver; dose reduction may be necessary in patients with liver disease. Thromboembolic disease: Caution in patients with thromboembolic diseases. Preexisting endometrial hyperplasia: Avoid long-term use.
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 1% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply